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Abstract
We aim to determine the incidence of early myocardial dysfunction after out-of-hospital cardiac 
arrest, risk factors associated with its development, and association with outcome. A retrospective 
chart review was performed among consecutive out-of-hospital cardiac arrest (OHCA) patients 
who underwent echocardiography within 24 h of return of spontaneous circulation at three urban 
teaching hospitals. Our primary outcome is early myocardial dysfunction, defined as a left 
ventricular ejection fraction < 40% on initial echocardiogram. We also determine risk factors 
associated with myocardial dysfunction using multivariate analysis, and examine its association 
with survival and neurologic outcome. A total of 190 patients achieved ROSC and underwent 
echocardiography within 24 h. Of these, 83 (44%) patients had myocardial dysfunction. A total of 
37 (45%) patients with myocardial dysfunction survived to discharge, 39% with intact neurologic 
status. History of congestive heart failure (OR 6.21; 95% CI 2.54–15.19), male gender (OR 2.27; 
95% CI 1.08–4.78), witnessed arrest (OR 4.20; 95% CI 1.78–9.93), more than three doses of 
epinephrine (OR 6.10; 95% CI 1.12–33.14), more than four defibrillations (OR 4.7; 95% CI 1.35–
16.43), longer duration of resuscitation (OR 1.06; 95% CI 1.01–1.10), and therapeutic 
hypothermia (OR 3.93; 95% CI 1.32–11.75) were associated with myocardial dysfunction. 
Cardiopulmonary resuscitation immediately initiated by healthcare personnel was associated with 
lower odds of myocardial dysfunction (OR 0.40; 95% CI 0.17–0.97). There was no association 
between early myocardial dysfunction and mortality or neurological outcome. Nearly half of 
OHCA patients have myocardial dysfunction. A number of clinical factors are associated with 
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myocardial dysfunction, and may aid providers in anticipating which patients need early 
diagnostic evaluation and specific treatments. Early myocardial dysfunction is not associated with 
neurologically intact survival.
Keywords
Cardiac arrest; Out-of-hospital; Myocardial dysfunction; Echocardiography; Neurological 
outcome
Introduction
Out-of-hospital cardiac arrest (OHCA) presents a considerable health burden in the United 
States, with an estimated incidence of 300,000 persons each year [1, 2]. Even though return 
of spontaneous circulation (ROSC) is achieved in 30–40% of OHCA patients, only 7% of 
patients receiving CPR will survive to hospital discharge, with significant geographic 
variability [1, 2].
Post-cardiac arrest syndrome (PCAS) is a complex constellation of multi-organ failure 
comprised of brain injury, systemic ischemia–reperfusion response, and post-cardiac arrest 
myocardial dysfunction, which contributes significantly to morbidity after cardiac arrest [2, 
3]. Myocardial dysfunction is an important cause of post-resuscitation circulatory failure 
that may lead to early mortality after ROSC [3, 4]. It is defined as reversible global 
dysfunction due to stunned myocardium in the absence of coronary occlusion [5–8]. 
Although post-cardiac arrest myocardial dysfunction is a potentially treatable complication, 
the severity and duration of the myocardial dysfunction may be associated with outcome [3, 
4, 7].
We aim to evaluate the incidence of post-cardiac arrest myocardial dysfunction, factors 
associated with its development, and its impact on outcome. Theoretically, factors that 
amplify ischemia–reperfusion injury should be associated with the presence and severity of 
post-arrest myocardial dysfunction. Therefore, we hypothesize that there would be an 
association between pre-hospital factors, including medical history, witnessed cardiac arrest, 
initial rhythm, bystander cardiopulmonary resuscitation (CPR), number of defibrillations, 
cumulative doses of epinephrine administrated during resuscitation, total downtime, and 
development of myocardial dysfunction after resuscitation.
Methods
Study design
We performed a retrospective data analysis utilizing the Penn Alliance for Therapeutic 
Hypothermia (PATH) database. PATH is an internet-based registry focusing on post-arrest 
care, which is hosted by the University of Pennsylvania.
In this study, consecutive OHCA patients treated in three urban teaching hospitals between 
May 2005 and December 2011 were screened for inclusion. Patients were included in this 
study if they were over the age of 17, suffered a non-traumatic arrest, achieved ROSC, and 
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had a documented echocardiogram performed within 24 h of their cardiac arrest. Exclusion 
criteria included the initiation of extracorporeal life support or a preexisting “Do Not 
Resuscitate” order. Research utilizing data in PATH was approved by the University of 
Pennsylvania Institutional Review Board with a waiver of informed consent.
Data collection
Patient demographics, cardiac arrest characteristics, details regarding prehospital and 
emergency department care, as well as patient outcomes were obtained from the PATH 
registry [9, 10]. Each patient record in PATH consists of 30 data elements required for 
quality assurance purposes from all participating institutions, and 100 additional data 
elements are required for research participation. Data were collected retrospectively at each 
of the participating institutions and entered into PATH via a secure, password-protected 
internet portal by a trained healthcare provider. Before entering data, these clinicians are first 
trained by the PATH database manager using a structured approach including mock case 
entry and case review. All participants are provided with a standardized data dictionary for 
PATH data elements and frequent telephone contact is made with each data abstracter early 
in registry participation. Additionally, a formal auditing process is conducted on a selection 
of cases to ensure data integrity, with feedback given to site abstractors for correction. The 
database manager has access to all entered records from each participating hospital.
Additional chart review was performed at three PATH institutions to obtain echocardiogram 
results, which were not available in the PATH registry. Transthoracic or transesophageal 
echocardiogram data were abstracted from clinical echocardiography reports interpreted by 
attending cardiologists by a single physician-abstractor who was trained by the principal 
investigator prior to the study. If there was more than one echocardiogram performed within 
24 h, the final one performed within the initial 24 h period was used for analysis. The 
principal investigator met regularly with the data abstractor to review abstracted charts and 
ensure data quality. The initial 30 charts were also reviewed by the principal investigator to 
ensure data quality and appropriate categorization. A kappa statistic was not calculated 
because agreement on left ventricular ejection fraction values was 100%. The abstractor was 
not blinded to the study hypothesis, but was blinded to patient outcomes.
The most readily available quantitative measure of myocardial function is the left ventricular 
ejection fraction (LVEF). According to 2010 Heart Failure Society of America guidelines, 
preserved LVEF is variably defined [11]. The American Heart Association (AHA) suggests 
that LVEF < 40% may indicate heart failure or cardiomyopathy while an LVEF between 40 
and 55% implies damage [12]. Accordingly, myocardial dysfunction is defined as LVEF < 
40% in this study, and is the variable of interest.
Outcome measures
Our primary outcome is post-cardiac arrest myocardial dysfunction. Secondary outcomes 
include survival to hospital discharge with favorable neurological outcome. Neurological 
outcome is measured using the cerebral performance category (CPC) score and 
dichotomized into favorable versus poor outcome. Favorable neurological outcome is 
defined as CPC score of 1 or 2 at hospital discharge.
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Statistical analyses
Descriptive statistics are used to summarize subject characteristics including median and 
interquartile range (IQR) for continuous variables, and number (n) and percentage (%) for 
categorical variables. We use Wilcoxon rank-sum test for continuous variables in univariate 
comparison and Chi-square tests for categorical variables. Multivariate logistic regression is 
then completed to adjust for variables influencing LVEF. Regression results are reported as 
odds ratios (ORs) with 95% confidence intervals (CI). Statistical analysis was performed 
using STATA 11.0 software (STATA 11.0, Statacorp, College Station, TX, USA).
Results
Between May 2005 and December 2011, 302 patients with OHCA successfully achieved 
ROSC and were transported to one of the three study hospitals. Nine patients (3%) were 
excluded because of major trauma as the cause of cardiac arrest (Fig.1). Median age in the 
cohort of patients with echocardiography performed within the study window is 60 years 
(IQR 48, 70) and 53% are male (Table 1). The majority of the cohort is black (56%). Most 
patients had a cardiac etiology for their arrests (78%) and a nonshockable rhythm (66%), 
and fewer than half received bystander CPR (47%) (Table 2). Echocardiography was 
performed in 221 patients (75%) and 190 (86%) of those patients had an echocardiogram 
performed within 24 after ROSC. A total of 83 patients (44%) had myocardial dysfunction 
within 24 h after ROSC. There is no difference in the median time from ROSC to 
echocardiogram when comparing patients with and without myocardial dysfunction (5.3 vs. 
7.1 h, p = 0.18).
When comparing patients with and without myocardial dysfunction, there is no difference in 
survival or favorable neurologic outcome. Men are more likely than women to have 
myocardial dysfunction (65 vs. 35%, p = 0.003) (Table 1). Duration of resuscitation is 
significantly longer in patients with myocardial dysfunction (25 vs. 20 min, p = 0.002). 
Patients who have myocardial dysfunction are more likely to have a history of congestive 
heart failure (CHF) (63 vs. 38%, p = 0.002) or coronary artery disease (34 vs. 17%, p = 
0.007). Finally, an OHCA event involving more than four defibrillations is more common in 
the myocardial dysfunction group (64 vs. 36%, p = 0.001).
In multivariate analysis, a number of factors are associated with myocardial dysfunction, 
including history of CHF, male gender, witnessed arrest, more than three doses of 
epinephrine, more than four defibrillations, longer duration of resuscitation, and therapeutic 
hypothermia (Fig. 2). CPR immediately initiated by health professional personnel is 
associated with better myocardial function. In addition, there is a significant interaction 
between duration of resuscitation and more than three doses of epinephrine used during 
resuscitation (OR 0.95; 95% CI 0.9–1.0).
Bystander CPR, immediate CPR from a healthcare professional, witnessed arrest, and 
shockable rhythm are associated with favorable neurologic outcome on multivariable 
analysis (Fig. 3). Advanced age, administration of epinephrine during resuscitation and 
longer duration of resuscitation are associated with poor outcome. There is no association 
between early myocardial dysfunction and neurological outcome.
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Discussion
We perform a cohort study of 190 patients after out-of-hospital cardiac arrest to examine 
predictors of post-arrest myocardial dysfunction and its association with outcome. We find 
associations between the following variables and myocardial dysfunction: male gender, 
history of CHF, witnessed arrest, longer duration of resuscitation, more than three doses of 
epinephrine, more than four defibrillations, and therapeutic hypothermia. CPR immediately 
initiated by a health professional is associated with a better LVEF. Mortality and 
neurological outcome are not significantly different when comparing patients with and 
without myocardial dysfunction.
Classically, post-cardiac arrest myocardial dysfunction is a transient global dysfunction that 
starts within minutes of arrest, becomes clinically apparent around 7 h after ROSC, and 
potentially recovers fully within 48–72 h [4, 5, 7, 8, 13, 14]. Our results confirm findings 
from previous studies that initial post-arrest myocardial dysfunction is not associated with 
neurologic outcome [4, 14].
Few studies have looked at clinical factors associated with post-arrest myocardial 
dysfunction. A previous study assessing hemodynamics in OHCA survivors reports that the 
amount of epinephrine used during CPR is associated with post-arrest instability, but not 
neurologic outcome [4]. Another study reports high doses of epinephrine as an independent 
predictor of post-resuscitation myocardial dysfunction, but demonstrates no association with 
neurologic outcome [14]. We find that a high epinephrine dose during CPR, as well as the 
duration of resuscitation, is associated with post-arrest myocardial dysfunction, and that 
there is an interaction between these two variables. Catecholamine excess has been 
described as a cause of myocardial dysfunction in other disease states, such as stress-
induced cardiomyopathy and subarachnoid hemorrhage [15, 16]. Because epinephrine dose 
and duration of resuscitation are tightly associated, it is difficult to determine if this is truly a 
pharmacologic effect, or simply related to prolonged ischemia and amplified reperfusion 
after ROSC.
We also find that repeated defibrillation is associated with myocardial dysfunction. The 
adverse effect of repeated defibrillation on myocardial function has been reported in 
laboratory studies [7, 8, 17–19]. The mechanism is not well understood, but may be related 
to increased intra-myocardial temperature causing myocardial damage, potentiated 
excitation–contraction uncoupling, dose-dependent release of free radicals, and waveform-
specific effects on mitochondrial function [20]. This finding, along with high doses of 
epinephrine and longer duration of resuscitation, suggests that individuals who develop post-
cardiac arrest myocardial dysfunction may have had more difficult, intervention-intensive 
resuscitative efforts prior to ROSC. It is also possible that both epinephrine dose and 
repeated defibrillation attempts are simply markers for prolonged resuscitation, which has 
itself been associated with post-arrest myocardial dysfunction.
In this study, we also compare predictors of neurological outcomes to those of post-cardiac 
arrest myocardial dysfunction. We find that factors traditionally associated with better 
neurological outcome may not reliably predict preserved myocardial function. Witnessed 
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cardiac arrest, as an independent predictor of favorable neurological outcome in multiple 
studies, is associated with myocardial dysfunction in our study [21]. Prior investigators 
demonstrate that patients with a cardiac etiology for their arrest are more likely to be 
witnessed, and have a higher prevalence of pre-existing cardiovascular disease, including 
congestive heart failure, previous myocardial infarction, angina pectoris, and hypertension 
[22]. In our study, there is a trend toward an increased prevalence of cardiac etiology among 
patients with witnessed arrest when compared with patients whose arrest was not witnessed 
(81 vs. 72%), but this did not reach statistical significance. It is possible that because more 
patients with witnessed arrest have a primary cardiac etiology or pre-existing cardiovascular 
disease, they are more likely to develop post-arrest myocardial dysfunction.
We also demonstrate that the use of therapeutic hypothermia (TH) is associated with 
myocardial dysfunction. The association between TH and myocardial function is complex, 
and should be interpreted cautiously. Therapeutic hypothermia as part of a standardized 
treatment for comatose survivors of cardiac arrest is recommended by the AHA due to its 
beneficial effect on both survival and neurological outcomes, but its effect on post-
resuscitation myocardial function remains unclear [23]. One study documents moderately 
reduced myocardial function among OHCA patients at the time of admission that increases 
upon induction of TH [24]. Animal models show that moderate TH preserves myocardial 
function, stabilizes hemodynamics, and decreases myocardial damage; others have not 
demonstrated such effects [25–30]. A sub-analysis of a recent, large randomized trial 
demonstrates a decrease in cardiac index in patients treated with TH at 33 °C compared with 
36 °C that is entirely attributable to heart rate; myocardial systolic function is not different 
between the groups [31]. In our study, one possible explanation for the association between 
TH and myocardial function is that patients who receive TH are different from those who do 
not. A total of 11 patients did not receive TH because they regained sufficient neurologic 
function shortly after ROSC; these patients will generally fare better than comatose patients 
with regard to neurologic outcome, survival, and, likely, myocardial function. In fact, only 
three of these patients had documented myocardial dysfunction.
Post-cardiac arrest myocardial dysfunction is a common component of PCAS, which can 
lead to early death [4, 32, 33]. In a recent large randomized trial, 46% of patients who died 
did so before thorough neurologic prognostication could occur because of a cardiac or 
hemodynamic cause [34]. These findings reinforce the need for early, aggressive 
hemodynamic evaluation and support. In a small pilot study, our group shows that early 
goal-directed hemodynamic optimization combined with TH is feasible and is associated 
with improved outcomes when compared to historical controls [35]. Other authors have 
suggested that every patient admitted to the ICU after ROSC should be screened for post-
cardiac arrest myocardial dysfunction because of its significant treatment implications, and 
because it can be easily identified with appropriate monitoring tools [36]. Echo-
cardiography is a safe, widely available, and relatively inexpensive clinical tool, which can 
provide both anatomical and functional information. The AHA guideline for post-cardiac 
arrest care suggests performing echocardiographic evaluation within 24 h to help guide 
therapeutic decisions [23]. It is possible that patients with risk factors for post-arrest 
myocardial dysfunction, as identified in this manuscript, might benefit from even more 
aggressive, earlier screening and early treatment [36–38]
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Limitations
This study has several limitations. Because this is a retrospective cohort registry study, the 
quality of data mainly relies on the accuracy of existing documentation, which may be 
incomplete or incorrect. We define myocardial dysfunction according to left ventricular 
function, so it is possible that patient with other forms of myocardial dysfunction, namely 
right ventricular dysfunction, were missed. Another factor is the limited availability of 
documentation of pre-arrest myocardial function in these individuals, which precludes the 
ability to account for baseline myocardial dysfunction. It is possible that some patients may 
have already had a low LVEF before their arrest. One study finds that LVEF decreases 
approximately 25% among in-hospital cardiac arrest survivors within 72 h regardless of their 
LVEF before cardiac arrest [37]. Importantly, we adjusted for a history of CHF in the 
multivariate analysis to control for a potential difference in baseline function. We also were 
unable to obtain follow up echocardiograms on all patients, so we could not demonstrate 
whether post-cardiac arrest myocardial dysfunction is transient or sustained. All patients in 
this study were treated at tertiary centers with comprehensive post-arrest care. Finally, 
selection bias may exist because patients who have echocardiographic evaluation after 
resuscitation may be significantly different from those who do not.
Conclusions
In survivors of out-of-hospital cardiac arrest, myocardial dysfunction is common in the early 
post-resuscitation phase. In our study, early myocardial dysfunction is not associated with 
survival or neurologic outcome. Systematic screening for post-arrest myocardial dysfunction 
should be considered to improve knowledge of this potentially dangerous sequela, and 
provide evidence to direct future management of these patients.
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Fig. 1. 
Flow diagram of patient enrollment, exclusions, and outcomes. OHCA out of hospital 
cardiac arrest, ROSC return of spontaneous circulation, Echo echocardiography, LVEF left 
ventricular ejection fraction
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Fig. 2. 
Factors significantly associated with myocardial dysfunction within 24 h post-arrest 
(multivariable analysis). Odds ratio > 1 indicates increased likelihood of myocardial 
dysfunction and odds ratio < 1 indicates decreased likelihood. CHF congestive heart failure, 
CPR cardiopulmonary resuscitation, mins minutes, CI confidence interval
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Fig. 3. 
Factors significantly associated favorable neurological outcome after out of hospital cardiac 
arrest (multivariable analysis). Odds ratio > 1 indicates increased likelihood of myocardial 
dysfunction and odds ratio < 1 indicates decreased likelihood. Favorable neurological 
outcome is defined as Cerebral Performance Category score of 1 or 2. CHF congestive heart 
failure, CPR cardiopulmonary resuscitation, mins minutes, CI confidence interval
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Table 1
Demographic characteristics and co-morbidities
All patients (n = 190) LVEF < 40% (n = 83) LVEF ≥ 40% (n = 107) p value
Gender, n (%) 0.003
 Male 101 (53) 55 (65) 46 (43)
 Female 90 (47) 29 (35) 61 (57)
Age, median (IQR), years 60 (48, 70) 60 (48, 70) 60 (48, 71) 0.811
Race, n (%) 0.22
 Black 105 (56) 48 (58) 57 (54)
 White 72 (38) 31 (38) 41 (39)
 Other 11 (6) 3 (4) 8 (7)
Preexisting conditions, n (%)
 Previous CHF 48 (25) 30 (36) 18 (17)
 Coronary artery disease 46 (24) 28 (33) 18 (17) 0.003
 Previous MI 22 (12) 12 (14) 10 (9) 0.008
 Hypertension 94 (49) 35 (42) 59 (55) 0.288
 Arrhythmia 6 (14) 12 (14) 14 (13) 0.064
 Diabetes mellitus 65 (34) 24 (29) 41 (38) 0.81
 Stroke 14 (7) 6 (7) 8 (7) 0.158
 Renal insufficiency 35 (18) 14 (17) 21 (20) 0.93
LVEF left ventricular ejection fraction, CHF congestive heart failure, MI myocardial infarct, IQR interquar-tile range
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Table 2
Out-of-hospital cardiac arrest event characteristics and post-arrest care
All patients (n = 190) LVEF < 40% (n = 83) LVEF ≥ 40% (n = 107) p valuea
Cardiac etiology 0.088
 Yes 148 (78) 69 (84) 79 (74)
 No 41 (22) 13 (16) 28 (26)
Witnessed event 0.131
 Yes 130 (68) 62 (74) 68 (64)
 No 61 (32) 22 (26) 39 (36)
Location 0.266
 Health care facility 58 (30) 22 (26) 36 (34)
 Non-healthcare facility 133 (70) 62 (74) 71 (66)
CPR 0.173
 Bystander 41 (21) 21 (25) 20 (19)
 Health Professional 61 (32) 21 (25) 40 (37)
 No 89 (47) 42 (50) 47 (44)
First pulseless rhythm, n (%) 0.079
 Shockable 65 (34) 34 (40) 31 (29)
 Non-shockable 126 (66) 50 (60) 76 (71)
Number of defibrillations 0.016
 No 81 (45) 28 (36) 53 (52)
 1–4 48 (27) 20 (26) 28 (28)
 > 4 50 (28) 30 (38) 20 (20)
Epinephrine 0.17
 No dose 47 (25) 16 (19) 31 (29)
 1–3 doses 74 (39) 31 (38) 43 (40)
 > 3 doses 68 (36) 30 (43) 33 (31)
Duration of resuscitation, median (IQR), min 21 (13,41) 25 (18, 47) 20 (10, 34) 0.001
Hypothermia 0.067
 Yes 160 (84) 75 (89) 85 (79)
 No 31 (16) 9 (11) 22 (21)
Duration of ROSC to echo median (IQR), h 6.25 (3.80, 11.38) 5.28 (3.18, 13.25) 7.07 (4.1, 11.22) 0.198
LVEF left ventricular ejection fraction, CPR cardiopulmonary resuscitation, IQR interquartile range, ROSC return of spontaneous circulation, Echo 
echocardiography 
aComparing patients with LVEF LVEF < 40% to those with LVEF ≥ 40%
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